RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'

March 6, 2024 4:18 PM

RBC Capital analyst Luca Issi reiterated a Sector Perform rating and $5.00 price target on WAVE Life Sciences (NASDAQ: WVE).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found